TABLEĀ 1.
Patient no. |
Age of onset (yr) |
Disease duration (mo) |
Gender | PRNP genotype at codon 129 |
sCJD subtype |
Clinical signs at onset |
Visual symptomsa |
Visuospatial dysfunctionb |
---|---|---|---|---|---|---|---|---|
1 | 60 | 1.5 | M | MM | 1 | Cognitive/visual | Yes | No |
2 | 60 | 20 | M | MV | 1-2 | Visuospatial | Yes | Yes |
3 | 69 | 15 | M | MV | 2 | Behavior/memory | No | No |
4 | 79 | 27 | M | MV | 2 | Cognitive | No | No |
5 | 55 | 6 | F | VV | 2 | Apraxia | Yes | No |
6 | 56 | 10 | F | MM | 1-2 | Language | No | No |
7 | 57 | 4 | F | MM | 1 | Motor | No | No |
8 | 55 | 24 | F | MV | 1-2 | Behavior | No | No |
9 | 63 | 2 | F | MM | 1 | Language | No | Yes |
10 | 69 | 6 | F | MV | 1 | Behavior/memory | No | No |
11 | 69 | 10 | F | MM | 1-2 | Cognitive/apraxia | No | Yes |
Visual symptoms noted at first through last UCSF visit.
Visuospatial dysfunction based on neuropsychological testing or neurological examination.